Condition: Sarcoma Metastatic · Locally Advanced Soft Tissue Sarcoma · Sponsor: Centre Oscar Lambret
ePPS-2202 is a study designed to evaluate the benefits of a dematerialised personalised care plan (PCP) compared to standard information/PCP for patients with advanced sarcomas receiving systemic treatment. Participants will be randomised to an experimental group or a control group. Patients in the experimental group will receive the dematerialised PCP in addition to the standard PCP while patients in the control group will receive the standard PCP alone. All patients will be followed until the end of second-line treatment, the start of a new line of treatment, or until the 24-month follow-up.
This description comes directly from the study's public registry record.
PANNIER Diane, DR · 03.20.29.59.59 · d-pannier@o-lambret.fr
THERY Julien, MD · J-THERY@o-lambret.fr
Always discuss trial participation with your own doctor first.
| Centre Léon Bérard | Lyon, Auvergne-Rhône-Alpes, France | Recruiting |
| CHU Jean Minjoz | Besançon, Bourgogne-Franche-Comté, France | Recruiting |
| Centre Eugène Marquis | Rennes, Brittany Region, France | Not Yet Recruiting |
| Centre Paul Strauss | Strasbourg, Grand Est, France | Recruiting |
| Centre Oscar Lambret | Lille, Hauts-de-France, France | Recruiting |
| CHU de Poitiers | Poitiers, New Aquitaine, France | Recruiting |
| Institut Claudius Regaud | Toulouse, Occitanie, France | Withdrawn |
| Institut de Cancérologie de l'Ouest | Saint-Herblain, Pays de la Loire Region, France | Recruiting |
| Institut de Cancérologie de Lorraine | Vandœuvre-lès-Nancy, France | Not Yet Recruiting |
| Hôpital Pitié-Salpêtrière AP-HP | Paris, Île-de-France Region, France | Not Yet Recruiting |
| Gustave Roussy | Villejuif, Île-de-France Region, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06211257